We deliver professional, regulation-aligned feasibility study and customized plant design services dedicated to biosimilar manufacturing projects, covering monoclonal antibodies, fusion proteins, insulin analogs and other complex biologic products. All analytical and design outputs fully comply with FDA, EMA, EU GMP and domestic biopharmaceutical regulatory requirements, adopting a product-centric development logic that balances technical feasibility, regulatory compliance, market accessibility and capital rationality. Unlike conventional pharmaceutical plant design, our solutions focus on the unique process specificity, similarity evaluation standards and strict quality control criteria of biosimilar projects, providing reliable pre-construction decision-making basis and compliant overall plant solutions.
Our systematic feasibility study covers full-dimensional project demonstration including market research, technical route verification, process scale-up analysis, site selection evaluation, utility demand calculation, investment budget and risk assessment. We conduct in-depth demonstration on cell culture amplification, protein purification, formulation preparation and sterile filling processes, verifying the rationality of production scale, process layout and quality control system to meet biosimilar consistency evaluation and batch production stability requirements. Meanwhile, we identify potential technical bottlenecks, compliance risks and cost control challenges in advance, forming optimized adjustment schemes to avoid project rework and investment losses.
Based on validated feasibility conclusions, we provide integrated plant design solutions tailored for large-scale, standardized biosimilar production. The overall design scientifically plans functional partitions including cell bank room, upstream fermentation workshop, downstream purification workshop, formulation & filling area, QC laboratory and auxiliary utility rooms, realizing complete separation of personnel flow, material flow and waste flow. We configure hierarchical clean environment standards and professional HVAC, purified water, process gas and exhaust treatment systems, fully adapting to the low-pollution, high-precision and high-stability production characteristics of biosimilar drugs, and meeting the whole-process quality management specifications of biologic products.
Our one-stop service integrates pre-project feasibility consultation, whole-process scheme design, compliance optimization, and design documentation validation support, creating scalable, cost-effective and certification-ready biosimilar manufacturing plants. We reserve flexible upgrade space for production lines and intelligent system interfaces to adapt to subsequent product pipeline expansion and process optimization. With rigorous data demonstration, standardized design specifications and rich biosimilar project experience, we help clients effectively shorten project landing cycles, reduce regulatory approval risks, and build high-standard manufacturing bases that meet global market commercialization requirements.
